No correlation was observed between TP53 mutations and TLS scoring in NSCLC although TP53-mutated tumors have a higher CD8+ T cell infiltrate and PD-L1 expression (38, 41). The gene discussed is TP53; the disease is non-small cell lung carcinoma.